170 related articles for article (PubMed ID: 22503609)
1. Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
Richey SL; Rao P; Wood CG; Patel S; Tannir NM
Clin Genitourin Cancer; 2012 Sep; 10(3):210-2. PubMed ID: 22503609
[No Abstract] [Full Text] [Related]
2. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin.
Ohgaki K; Horiuchi K; Mizutani S; Sato M; Kondo Y
Int J Clin Oncol; 2010 Apr; 15(2):210-4. PubMed ID: 20186557
[TBL] [Abstract][Full Text] [Related]
3. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Kushner BH; Meyers PA
J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
[TBL] [Abstract][Full Text] [Related]
4. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
6. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
[TBL] [Abstract][Full Text] [Related]
7. Primary extraskeletal Ewing's sarcoma/primitive neuroectodermal tumour of breast.
Ikhwan SM; Kenneth VK; Seoparjoo A; Zin AA
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23813511
[TBL] [Abstract][Full Text] [Related]
8. Extraosseous Ewing's sarcoma of the kidney.
Dogra PN; Goel A; Kumar R; Das PK; Gupta SD
Urol Int; 2002; 69(2):150-2. PubMed ID: 12187048
[TBL] [Abstract][Full Text] [Related]
9. Organ-confined primitive neuroectodermal tumor arising from the kidney.
Lam JS; Hensle TW; Debelenko L; Granowetter L; Tennenbaum SY
J Pediatr Surg; 2003 Apr; 38(4):619-21. PubMed ID: 12677579
[TBL] [Abstract][Full Text] [Related]
10. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours.
Verrill MW; Judson IR; Wiltshaw E; Thomas JM; Harmer CL; Fisher C
Ann Oncol; 1997 Nov; 8(11):1099-105. PubMed ID: 9426329
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcoma.
DuBois SG; Grier HE
Nat Rev Clin Oncol; 2009 May; 6(5):251-3. PubMed ID: 19390548
[TBL] [Abstract][Full Text] [Related]
12. Ewing's sarcoma/PNET of kidney in 13-year-old girl.
Badar Q; Ali N; Abbasi N; Ashraf S; Karsan F; Hashmi R
J Pak Med Assoc; 2010 Apr; 60(4):314-5. PubMed ID: 20419980
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.
Marina NM; Pappo AS; Parham DM; Cain AM; Rao BN; Poquette CA; Pratt CB; Greenwald C; Meyer WH
J Clin Oncol; 1999 Jan; 17(1):180-90. PubMed ID: 10458232
[TBL] [Abstract][Full Text] [Related]
14. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
Milano GM; Cozza R; Ilari I; De Sio L; Boldrini R; Jenkner A; De Ioris M; Inserra A; Dominici C; Donfrancesco A
Cancer; 2006 Apr; 106(8):1838-45. PubMed ID: 16532434
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
[TBL] [Abstract][Full Text] [Related]
16. Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy.
Gururangan S; Marina NM; Luo X; Parham DM; Tzen CY; Greenwald CA; Rao BN; Kun LE; Meyer WH
J Pediatr Hematol Oncol; 1998; 20(1):55-61. PubMed ID: 9482414
[TBL] [Abstract][Full Text] [Related]
17. Ewing's sarcoma of the inferior vena cava.
Mahmood A; Cleasby M; Hübscher SG; Khaira HS
Vasc Endovascular Surg; 2009; 43(4):403-5. PubMed ID: 19351649
[TBL] [Abstract][Full Text] [Related]
18. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Bhatia S; Krailo MD; Chen Z; Burden L; Askin FB; Dickman PS; Grier HE; Link MP; Meyers PA; Perlman EJ; Rausen AR; Robison LL; Vietti TJ; Miser JS
Blood; 2007 Jan; 109(1):46-51. PubMed ID: 16985182
[TBL] [Abstract][Full Text] [Related]
19. Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor.
Ehrlich Y; Beck SDW; Ulbright TM; Cheng L; Brames MJ; Andreoiu M; Foster RS; Einhorn LH
Ann Oncol; 2010 Sep; 21(9):1846-1850. PubMed ID: 20231305
[TBL] [Abstract][Full Text] [Related]
20. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
